Bill Title: Requiring drug manufacturers to provide pricing under the federal 340B drug pricing program to pharmacies that enter into contractual agreements with entities covered under the 340B program and prohibiting pharmacy benefits managers from denying patients the freedom to use the pharmacy and healthcare provider of such patient's choice.

Sponsorship: Committee Bill

Status: (Failed) 2024-04-30 - Senate Died in Committee [SB236 Detail]

Text: Latest bill text (Introduced) [PDF]

---

PolitiCorps Conversations

Start PolitiCorps Debate

Title	PolitiCorps	Access	Comments	Views	Last Post
There are no visible public or private PolitiCorps discussions concerning the 2023 Kansas SB236 at this time.